ImportRefusal LogoImportRefusal

Laboratorios Spaisons Ltda

⚠️ Moderate Risk

FEI: 3003142018 • Bogota, Cundinamarca • COLOMBIA

FEI

FEI Number

3003142018

📍

Location

Bogota, Cundinamarca

🇨🇴

Country

COLOMBIA
🏢

Address

Diagonal 3d #4470 / 72, , Bogota, Cundinamarca, Colombia

Moderate Risk

FDA Import Risk Assessment

40.4
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

11
Total Refusals
5
Unique Violations
6/10/2005
Latest Refusal
5/17/2005
Earliest Refusal

Score Breakdown

Violation Severity
46.0×40%
Refusal Volume
40.0×30%
Recency
0.0×20%
Frequency
100.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1189×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

4732×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

4742×

COSMETLBLG

It appears the label does not bear the common or usual name of the cosmetic.

4711×

CSTIC LBLG

The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.

4751×

COSMETLBLG

It appears that the cosmetic consists of two or more ingredients and the label does not list the common or usual name of each ingredient.

Refusal History

DateProductViolationsDivision
6/10/2005
53LC99OTHER SKIN CARE PREPARATIONS, N.E.C.
473LABELING
474COSMETLBLG
Florida District Office (FLA-DO)
6/10/2005
53LC99OTHER SKIN CARE PREPARATIONS, N.E.C.
471CSTIC LBLG
473LABELING
474COSMETLBLG
475COSMETLBLG
Florida District Office (FLA-DO)
6/10/2005
53LC99OTHER SKIN CARE PREPARATIONS, N.E.C.
118NOT LISTED
Florida District Office (FLA-DO)
6/10/2005
53LH99OTHER SKIN CARE PREPARATIONS, N.E.C.
118NOT LISTED
Florida District Office (FLA-DO)
6/10/2005
53LD99OTHER SKIN CARE PREPARATIONS, N.E.C.
118NOT LISTED
Florida District Office (FLA-DO)
6/10/2005
53LC99OTHER SKIN CARE PREPARATIONS, N.E.C.
118NOT LISTED
Florida District Office (FLA-DO)
6/10/2005
53LC99OTHER SKIN CARE PREPARATIONS, N.E.C.
118NOT LISTED
Florida District Office (FLA-DO)
6/10/2005
53LC99OTHER SKIN CARE PREPARATIONS, N.E.C.
118NOT LISTED
Florida District Office (FLA-DO)
6/10/2005
53LC99OTHER SKIN CARE PREPARATIONS, N.E.C.
118NOT LISTED
Florida District Office (FLA-DO)
5/17/2005
53LC99OTHER SKIN CARE PREPARATIONS, N.E.C.
118NOT LISTED
Division of Southeast Imports (DSEI)
5/17/2005
53LD99OTHER SKIN CARE PREPARATIONS, N.E.C.
118NOT LISTED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is Laboratorios Spaisons Ltda's FDA import refusal history?

Laboratorios Spaisons Ltda (FEI: 3003142018) has 11 FDA import refusal record(s) in our database, spanning from 5/17/2005 to 6/10/2005.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Laboratorios Spaisons Ltda's FEI number is 3003142018.

What types of violations has Laboratorios Spaisons Ltda received?

Laboratorios Spaisons Ltda has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Laboratorios Spaisons Ltda come from?

All FDA import refusal data for Laboratorios Spaisons Ltda is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.